Identification of Cellular Damage in Uteri From Hyperinsulinemic Mice Treated With Unopposed Estradiol

Unopposed estradiol and obesity are known risk factors for endometrial adenocarcinoma (EC). Endometrium from women with obesity was found to have an increase in mutations relative to tissue from normal weight women, indicating DNA damage may be accelerated in the setting of obesity. Since obesity is...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the Endocrine Society 2021-05, Vol.5 (Supplement_1), p.A750-A751
Hauptverfasser: Kelly, Katherine C, Huang, Jane, Joshi, Aditi A, Tal, Aya, Wong, Serena, Flannery, Clare A
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page A751
container_issue Supplement_1
container_start_page A750
container_title Journal of the Endocrine Society
container_volume 5
creator Kelly, Katherine C
Huang, Jane
Joshi, Aditi A
Tal, Aya
Wong, Serena
Flannery, Clare A
description Unopposed estradiol and obesity are known risk factors for endometrial adenocarcinoma (EC). Endometrium from women with obesity was found to have an increase in mutations relative to tissue from normal weight women, indicating DNA damage may be accelerated in the setting of obesity. Since obesity is associated with high levels of insulin and anovulatory cycles, we sought to mimic these conditions in a mouse model. We previously found that hyperinsulinemic MKR mice, without the confounder of obesity, have an increased incidence of nuclear atypia in endometrial glands. We hypothesized that hyperinsulinemia and unopposed estradiol have a synergistic effect on inducing abnormal architecture and DNA damage in the endometrium, than either alone. At 8-10 weeks old, cohorts of MKR (n=20) and WT (n=20) mice underwent ovariectomy and placement of either an estradiol (E2) or placebo (P) pellet. Metabolic profiling included insulin tolerance testing and MR for body composition. At 3 months post-implantation, mice received a partial hysterectomy and second pellet replacement. At 6 months, the remaining uterus was bisected into pieces. A blinded histological analysis was conducted by a gynecology pathologist. A marker of DNA damage due to oxidative stress, 8-oxoguanine-DNA-glycosylase (8-OHdG), was quantified by ELISA. Data was analyzed using Kruskal-Wallis test with multiple test correction, or Fischer’s exact test. By 6 months, MKR-E2 treated mice had a 27% lower body weight than MKR-P mice (p
doi_str_mv 10.1210/jendso/bvab048.1526
format Article
fullrecord <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_1210_jendso_bvab048_1526</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_1210_jendso_bvab048_1526</sourcerecordid><originalsourceid>FETCH-LOGICAL-c896-4427609b58373f3a51dfae74127f7d6c9515e575fadec2adce854e5684862ab93</originalsourceid><addsrcrecordid>eNpN0L1uwjAcBHCraqUiyhN08QsE_BnHY0WhIFF1AXWMHPvv1iiJIzutxNsXBEOnu1tu-CH0TMmcMkoWR-hdjovm1zREVHMqWXmHJkwoVlCt2P2__ohmOR8JIVRzoYWYIL910I_BB2vGEHscPV5C2_60JuFX05kvwKHHhxFSwOsUO7w5Defe55829NAFi9-DBbxPYEZw-DOM3_jQx2GI-TxXeUzGhdg-oQdv2gyzW07Rfr3aLzfF7uNtu3zZFbbSZSEEUyXRjay44p4bSZ03oARlyitXWi2pBKmkNw4sM85CJQXIshJVyUyj-RTx661NMecEvh5S6Ew61ZTUF6z6ilXfsOoLFv8DPathbw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Identification of Cellular Damage in Uteri From Hyperinsulinemic Mice Treated With Unopposed Estradiol</title><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Oxford Journals Open Access Collection</source><source>PubMed Central</source><creator>Kelly, Katherine C ; Huang, Jane ; Joshi, Aditi A ; Tal, Aya ; Wong, Serena ; Flannery, Clare A</creator><creatorcontrib>Kelly, Katherine C ; Huang, Jane ; Joshi, Aditi A ; Tal, Aya ; Wong, Serena ; Flannery, Clare A</creatorcontrib><description>Unopposed estradiol and obesity are known risk factors for endometrial adenocarcinoma (EC). Endometrium from women with obesity was found to have an increase in mutations relative to tissue from normal weight women, indicating DNA damage may be accelerated in the setting of obesity. Since obesity is associated with high levels of insulin and anovulatory cycles, we sought to mimic these conditions in a mouse model. We previously found that hyperinsulinemic MKR mice, without the confounder of obesity, have an increased incidence of nuclear atypia in endometrial glands. We hypothesized that hyperinsulinemia and unopposed estradiol have a synergistic effect on inducing abnormal architecture and DNA damage in the endometrium, than either alone. At 8-10 weeks old, cohorts of MKR (n=20) and WT (n=20) mice underwent ovariectomy and placement of either an estradiol (E2) or placebo (P) pellet. Metabolic profiling included insulin tolerance testing and MR for body composition. At 3 months post-implantation, mice received a partial hysterectomy and second pellet replacement. At 6 months, the remaining uterus was bisected into pieces. A blinded histological analysis was conducted by a gynecology pathologist. A marker of DNA damage due to oxidative stress, 8-oxoguanine-DNA-glycosylase (8-OHdG), was quantified by ELISA. Data was analyzed using Kruskal-Wallis test with multiple test correction, or Fischer’s exact test. By 6 months, MKR-E2 treated mice had a 27% lower body weight than MKR-P mice (p&lt;0.05), and 31% lower than WT-E2 mice (p&lt;0.01). WT-E2 and WT-P had similar weight, and were similar to MKR-P (p=ns). Percent body fat was similar across all 4 cohorts of mice (p=ns). Since placebo-treated mice had small, atrophied uteri with minimal gland formation, E2 pellet failure was determined by the presence of small, atrophied uteri and occurred in 4 MKR and 3 WT mice at either 3 or 6 months. All other MKR and WT E2 treated mice had enlarged uteri. The frequency of endometrial gland dilation was similar in MKR-E2 and WT-E2 uteri (p=ns), but all MKR mice had moderate-severe dilation, whereas WT mice had 50% mild and 50% moderate-severe dilation (p=0.07). Focal hyperplasia was present in one MKR-E2 mouse, and nuclear atypia was present in one WT-E2 mouse. MKR-P uteri had a 7-fold higher mean 8-OHdG relative to MKR-E2 uteri (5.0±3.7 vs 0.7±1.6, p&lt;0.002). WT-E2 and WT-P uteri had similar 8-OHdG (1.6±0.8 vs 1.8±0.6, p=ns), as did MKR-E2 and WT-E2 uteri (p=ns). Our findings show that hyperinsulinemia exacerbates the cystic dilation induced by chronic unopposed estradiol, indicating a synergy of insulin and estradiol in promoting abnormal glandular growth in the endometrium. Surprisingly, uterine DNA damage was highest in the setting of hyperinsulinemia alone, in a hormonal state mimicking post-menopause. Further work is needed to understand the effect of estradiol on intrauterine oxidative stress-induced damage.</description><identifier>ISSN: 2472-1972</identifier><identifier>EISSN: 2472-1972</identifier><identifier>DOI: 10.1210/jendso/bvab048.1526</identifier><language>eng</language><ispartof>Journal of the Endocrine Society, 2021-05, Vol.5 (Supplement_1), p.A750-A751</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,864,27915,27916</link.rule.ids></links><search><creatorcontrib>Kelly, Katherine C</creatorcontrib><creatorcontrib>Huang, Jane</creatorcontrib><creatorcontrib>Joshi, Aditi A</creatorcontrib><creatorcontrib>Tal, Aya</creatorcontrib><creatorcontrib>Wong, Serena</creatorcontrib><creatorcontrib>Flannery, Clare A</creatorcontrib><title>Identification of Cellular Damage in Uteri From Hyperinsulinemic Mice Treated With Unopposed Estradiol</title><title>Journal of the Endocrine Society</title><description>Unopposed estradiol and obesity are known risk factors for endometrial adenocarcinoma (EC). Endometrium from women with obesity was found to have an increase in mutations relative to tissue from normal weight women, indicating DNA damage may be accelerated in the setting of obesity. Since obesity is associated with high levels of insulin and anovulatory cycles, we sought to mimic these conditions in a mouse model. We previously found that hyperinsulinemic MKR mice, without the confounder of obesity, have an increased incidence of nuclear atypia in endometrial glands. We hypothesized that hyperinsulinemia and unopposed estradiol have a synergistic effect on inducing abnormal architecture and DNA damage in the endometrium, than either alone. At 8-10 weeks old, cohorts of MKR (n=20) and WT (n=20) mice underwent ovariectomy and placement of either an estradiol (E2) or placebo (P) pellet. Metabolic profiling included insulin tolerance testing and MR for body composition. At 3 months post-implantation, mice received a partial hysterectomy and second pellet replacement. At 6 months, the remaining uterus was bisected into pieces. A blinded histological analysis was conducted by a gynecology pathologist. A marker of DNA damage due to oxidative stress, 8-oxoguanine-DNA-glycosylase (8-OHdG), was quantified by ELISA. Data was analyzed using Kruskal-Wallis test with multiple test correction, or Fischer’s exact test. By 6 months, MKR-E2 treated mice had a 27% lower body weight than MKR-P mice (p&lt;0.05), and 31% lower than WT-E2 mice (p&lt;0.01). WT-E2 and WT-P had similar weight, and were similar to MKR-P (p=ns). Percent body fat was similar across all 4 cohorts of mice (p=ns). Since placebo-treated mice had small, atrophied uteri with minimal gland formation, E2 pellet failure was determined by the presence of small, atrophied uteri and occurred in 4 MKR and 3 WT mice at either 3 or 6 months. All other MKR and WT E2 treated mice had enlarged uteri. The frequency of endometrial gland dilation was similar in MKR-E2 and WT-E2 uteri (p=ns), but all MKR mice had moderate-severe dilation, whereas WT mice had 50% mild and 50% moderate-severe dilation (p=0.07). Focal hyperplasia was present in one MKR-E2 mouse, and nuclear atypia was present in one WT-E2 mouse. MKR-P uteri had a 7-fold higher mean 8-OHdG relative to MKR-E2 uteri (5.0±3.7 vs 0.7±1.6, p&lt;0.002). WT-E2 and WT-P uteri had similar 8-OHdG (1.6±0.8 vs 1.8±0.6, p=ns), as did MKR-E2 and WT-E2 uteri (p=ns). Our findings show that hyperinsulinemia exacerbates the cystic dilation induced by chronic unopposed estradiol, indicating a synergy of insulin and estradiol in promoting abnormal glandular growth in the endometrium. Surprisingly, uterine DNA damage was highest in the setting of hyperinsulinemia alone, in a hormonal state mimicking post-menopause. Further work is needed to understand the effect of estradiol on intrauterine oxidative stress-induced damage.</description><issn>2472-1972</issn><issn>2472-1972</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNpN0L1uwjAcBHCraqUiyhN08QsE_BnHY0WhIFF1AXWMHPvv1iiJIzutxNsXBEOnu1tu-CH0TMmcMkoWR-hdjovm1zREVHMqWXmHJkwoVlCt2P2__ohmOR8JIVRzoYWYIL910I_BB2vGEHscPV5C2_60JuFX05kvwKHHhxFSwOsUO7w5Defe55829NAFi9-DBbxPYEZw-DOM3_jQx2GI-TxXeUzGhdg-oQdv2gyzW07Rfr3aLzfF7uNtu3zZFbbSZSEEUyXRjay44p4bSZ03oARlyitXWi2pBKmkNw4sM85CJQXIshJVyUyj-RTx661NMecEvh5S6Ew61ZTUF6z6ilXfsOoLFv8DPathbw</recordid><startdate>20210503</startdate><enddate>20210503</enddate><creator>Kelly, Katherine C</creator><creator>Huang, Jane</creator><creator>Joshi, Aditi A</creator><creator>Tal, Aya</creator><creator>Wong, Serena</creator><creator>Flannery, Clare A</creator><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20210503</creationdate><title>Identification of Cellular Damage in Uteri From Hyperinsulinemic Mice Treated With Unopposed Estradiol</title><author>Kelly, Katherine C ; Huang, Jane ; Joshi, Aditi A ; Tal, Aya ; Wong, Serena ; Flannery, Clare A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c896-4427609b58373f3a51dfae74127f7d6c9515e575fadec2adce854e5684862ab93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kelly, Katherine C</creatorcontrib><creatorcontrib>Huang, Jane</creatorcontrib><creatorcontrib>Joshi, Aditi A</creatorcontrib><creatorcontrib>Tal, Aya</creatorcontrib><creatorcontrib>Wong, Serena</creatorcontrib><creatorcontrib>Flannery, Clare A</creatorcontrib><collection>CrossRef</collection><jtitle>Journal of the Endocrine Society</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kelly, Katherine C</au><au>Huang, Jane</au><au>Joshi, Aditi A</au><au>Tal, Aya</au><au>Wong, Serena</au><au>Flannery, Clare A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Identification of Cellular Damage in Uteri From Hyperinsulinemic Mice Treated With Unopposed Estradiol</atitle><jtitle>Journal of the Endocrine Society</jtitle><date>2021-05-03</date><risdate>2021</risdate><volume>5</volume><issue>Supplement_1</issue><spage>A750</spage><epage>A751</epage><pages>A750-A751</pages><issn>2472-1972</issn><eissn>2472-1972</eissn><abstract>Unopposed estradiol and obesity are known risk factors for endometrial adenocarcinoma (EC). Endometrium from women with obesity was found to have an increase in mutations relative to tissue from normal weight women, indicating DNA damage may be accelerated in the setting of obesity. Since obesity is associated with high levels of insulin and anovulatory cycles, we sought to mimic these conditions in a mouse model. We previously found that hyperinsulinemic MKR mice, without the confounder of obesity, have an increased incidence of nuclear atypia in endometrial glands. We hypothesized that hyperinsulinemia and unopposed estradiol have a synergistic effect on inducing abnormal architecture and DNA damage in the endometrium, than either alone. At 8-10 weeks old, cohorts of MKR (n=20) and WT (n=20) mice underwent ovariectomy and placement of either an estradiol (E2) or placebo (P) pellet. Metabolic profiling included insulin tolerance testing and MR for body composition. At 3 months post-implantation, mice received a partial hysterectomy and second pellet replacement. At 6 months, the remaining uterus was bisected into pieces. A blinded histological analysis was conducted by a gynecology pathologist. A marker of DNA damage due to oxidative stress, 8-oxoguanine-DNA-glycosylase (8-OHdG), was quantified by ELISA. Data was analyzed using Kruskal-Wallis test with multiple test correction, or Fischer’s exact test. By 6 months, MKR-E2 treated mice had a 27% lower body weight than MKR-P mice (p&lt;0.05), and 31% lower than WT-E2 mice (p&lt;0.01). WT-E2 and WT-P had similar weight, and were similar to MKR-P (p=ns). Percent body fat was similar across all 4 cohorts of mice (p=ns). Since placebo-treated mice had small, atrophied uteri with minimal gland formation, E2 pellet failure was determined by the presence of small, atrophied uteri and occurred in 4 MKR and 3 WT mice at either 3 or 6 months. All other MKR and WT E2 treated mice had enlarged uteri. The frequency of endometrial gland dilation was similar in MKR-E2 and WT-E2 uteri (p=ns), but all MKR mice had moderate-severe dilation, whereas WT mice had 50% mild and 50% moderate-severe dilation (p=0.07). Focal hyperplasia was present in one MKR-E2 mouse, and nuclear atypia was present in one WT-E2 mouse. MKR-P uteri had a 7-fold higher mean 8-OHdG relative to MKR-E2 uteri (5.0±3.7 vs 0.7±1.6, p&lt;0.002). WT-E2 and WT-P uteri had similar 8-OHdG (1.6±0.8 vs 1.8±0.6, p=ns), as did MKR-E2 and WT-E2 uteri (p=ns). Our findings show that hyperinsulinemia exacerbates the cystic dilation induced by chronic unopposed estradiol, indicating a synergy of insulin and estradiol in promoting abnormal glandular growth in the endometrium. Surprisingly, uterine DNA damage was highest in the setting of hyperinsulinemia alone, in a hormonal state mimicking post-menopause. Further work is needed to understand the effect of estradiol on intrauterine oxidative stress-induced damage.</abstract><doi>10.1210/jendso/bvab048.1526</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2472-1972
ispartof Journal of the Endocrine Society, 2021-05, Vol.5 (Supplement_1), p.A750-A751
issn 2472-1972
2472-1972
language eng
recordid cdi_crossref_primary_10_1210_jendso_bvab048_1526
source DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Oxford Journals Open Access Collection; PubMed Central
title Identification of Cellular Damage in Uteri From Hyperinsulinemic Mice Treated With Unopposed Estradiol
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T04%3A18%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Identification%20of%20Cellular%20Damage%20in%20Uteri%20From%20Hyperinsulinemic%20Mice%20Treated%20With%20Unopposed%20Estradiol&rft.jtitle=Journal%20of%20the%20Endocrine%20Society&rft.au=Kelly,%20Katherine%20C&rft.date=2021-05-03&rft.volume=5&rft.issue=Supplement_1&rft.spage=A750&rft.epage=A751&rft.pages=A750-A751&rft.issn=2472-1972&rft.eissn=2472-1972&rft_id=info:doi/10.1210/jendso/bvab048.1526&rft_dat=%3Ccrossref%3E10_1210_jendso_bvab048_1526%3C/crossref%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true